Cytotoxic Assessment of Carbon Nanotube Interaction with Cell Cultures

  • Hanene Ali-Boucetta
  • Khuloud T. Al-Jamal
  • Kostas Kostarelos
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 726)

Abstract

The field of nanotoxicology recently has emerged out of the need to systematically study the biocompatibility and potential adverse effects of novel nanomaterials. Carbon nanotubes (CNT) are one of the most interesting types of nanomaterials, and recently, their use in applications has dramatically increased. Their potential adverse impact on human health and the environment, however, have caused them to be viewed with apprehension in certain cases so further studies into their toxicology are justified. Current methodologies using cell culture (in vitro) models are unreliable and are not yet able to offer conclusive results about the toxicity profile of CNT. The need for reliable and rapid toxicity assays that will allow high throughput screening of nanotube materials is a prerequisite for the valid assessment of CNT toxicity. The assay described here was developed based on the pitfalls and drawbacks of traditionally used cytotoxicity assays. A methodological description of the main problems associated with the MTT and the LDH assays is offered to illustrate the advantages of this novel assay for the study and determination of the cytotoxic profile of CNT. Most importantly, a thorough account of this novel assay which is considered to be rapid, reliable, and suitable for broad-spectrum cytotoxicity screening of different types of CNT is described.

Key words

Nanotechnology Nanotoxicology MTT LDH Fluorescence Cell death Apoptosis 

Notes

Acknowledgments

This work was partially supported by the European Union FP7 ANTICARB (HEALTH-2007-201587) program. H.A.-B. wishes to acknowledge the Ministére de l’Enseignement Supèrieur et de la Recherche Scientifique (Algeria) for a full Ph.D. scholarship.

References

  1. 1.
    Kostarelos, K., Bianco, A., and Prato, M. (2009) Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 4, 627–633.CrossRefGoogle Scholar
  2. 2.
    Bianco, A. and Prato, M. (2003) Can carbon nanotubes be considered useful tools for biological applications? Adv. Mater. 15, 1765–1768.CrossRefGoogle Scholar
  3. 3.
    Prato, M., Kostarelos, K., and Bianco, A. (2008) Functionalized carbon nanotubes in drug design and discovery. Acc. Chem. Res. 41, 60–68.CrossRefGoogle Scholar
  4. 4.
    Ali-Boucetta, H., Al-Jamal, K. T., McCarthy, D., Prato, M., Bianco, A., and Kostarelos, K. (2008) Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem. Commun. 4, 459–461.CrossRefGoogle Scholar
  5. 5.
    Podesta, J. E., Al-Jamal, K. T., Herrero, M. A., Tian, B., Ali-Boucetta, H., Hegde, V., et al. (2009) Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model. Small 5, 1176–1185.CrossRefGoogle Scholar
  6. 6.
    Pastorin, G., Wu, W., Wieckowski, S., Briand, J. -P., Kostarelos, K., Prato, M., et al. (2006) Double functionalization of carbon nanotubes for multimodal drug delivery. Chem. Commun. 11, 1182–1184.CrossRefGoogle Scholar
  7. 7.
    Worle-Knirsch, J. M., Pulskamp, K., and Krug, H. F. (2006) Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 6, 1261–1268.CrossRefGoogle Scholar
  8. 8.
    Casey, A., Herzog, E., Davoren, M., Lyng, F. M., Byrne, H. J., and Chambers, G. (2007) Spectroscopic analysis confirms the interactions between single walled carbon nanotubes and various dyes commonly used to assess cytotoxicity. Carbon 45, 1425–1432.CrossRefGoogle Scholar
  9. 9.
    Casey, A., Davoren, M., Herzog, E., Lyng, F. M., Byrne, H. J., and Chambers, G. (2007) Probing the interaction of single walled carbon nanotubes within cell culture medium as a precursor to toxicity testing. Carbon 45, 34–40.CrossRefGoogle Scholar
  10. 10.
    Monteiro-Riviere, N. A. and Inman, A. O. (2006) Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 44, 1070–1078.CrossRefGoogle Scholar
  11. 11.
    Monteiro-Riviere, N. A., Inman, A. O., and Zhang, L. W. (2009) Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 234, 222–235.CrossRefGoogle Scholar
  12. 12.
    Davoren, M., Herzog, E., Casey, A., Cottineau, B., Chambers, G., Bryne, H. J., et al. (2007) In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol. In Vitro 21, 438–448.CrossRefGoogle Scholar
  13. 13.
    Herzog, E., Casey, A., Lyng, F. M., Chambers, G., Byrne, H. J., and Davoren, M. (2007) A new approach to the toxicity testing of carbon-based nanomaterials – The clonogenic assay. Toxicol. Lett. 174, 49–60.CrossRefGoogle Scholar
  14. 14.
    Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63.CrossRefGoogle Scholar
  15. 15.
    CytoTox 96 Non-Radioactive Cytotoxicity Assay-Technical Bulletin. http://www.promega.com/catalog/catalogproducts.aspx?categoryname=productleaf_405. Accessed 2010.

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Hanene Ali-Boucetta
  • Khuloud T. Al-Jamal
  • Kostas Kostarelos
    • 1
  1. 1.Centre for Drug Delivery Research, The School of PharmacyUniversity of LondonLondonUK

Personalised recommendations